Daniel Faga, CEO at ANAPTYSBIO, INC (ANAB), sold 645,321 shares at $22.78 ($14.3M) on 2024-03-22, disclosed to the SEC on 2024-03-26.
Open-market sale of $14.3M ANAB by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.78 | 145,940 | $3.3M | 23.3% |
| 2 | $22.78 | 145,940 | $3.3M | 23.3% |
| 3 | $21.42 | 3,000 | $64K | 0.4% |
| 4 | $21.42 | 3,000 | $64K | 0.4% |
| 5 | $21.60 | 347,441 | $7.5M | 52.5% |
| Total | $22.13 avg | 645,321 |
| $14.3M |
| 100% |
| Filing → |
| ANAB | SELL | 2026-01-08 | $415K | — | Filing → |
| ANAB | SELL | 2026-01-06 | $662K | — | Filing → |
| ANAB | SELL | 2024-01-09 | $299K | — | Filing → |